Pfizer Strikes $2.6 Billion Deal for Experimental Autoimmune Therapies
Pfizer licensed exclusive rights outside Greater China to develop, manufacture and commercialize three experimental autoimmune treatments from Starna Therapeutics.
By Connor HartPfizer entered into a licensing agreement with Starna Therapeutics, obtaining exclusive rights outside Greater China to develop, manufacture and commercialize three early-stage, experimental treatments for autoimmune diseases.Under the agreement, Starna will receive an upfront payment…